Education
About Us
Working with TipRanks
Follow Us
Omega Diagnostics Group PLC (GB:CNSL)
LSE:CNSL
Total Valuation
Omega Diagnostics has a market cap or net worth of £6.90M. The enterprise value is 2.74M.
Market Cap£6.90M
Enterprise Value2.74M
Share Statistics
Omega Diagnostics has 237,950,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding237,950,650
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Omega Diagnostics’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is -5.37%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.11
Return on Invested Capital (ROIC)-5.37%
Return on Capital Employed (ROCE)-0.05
Revenue Per Employee88.62K
Profits Per Employee16.66K
Employee Count94
Asset Turnover0.60
Inventory Turnover4.01
Valuation Ratios
The current PE Ratio of Omega Diagnostics is 4.3. Omega Diagnostics’s PEG ratio is -0.00812.
PE Ratio4.3
PS Ratio0.87
PB Ratio0.64
Price to Fair Value0.64
Price to FCF-51.18
Price to Operating Cash Flow81.71
PEG Ratio-0.00812
Income Statement
In the last 12 months, Omega Diagnostics had revenue of 8.33M and earned 1.57M in profits. Earnings per share was 0.01.
Revenue8.33M
Gross Profit5.00M
Operating Income-640.00K
Pretax Income1.57M
Net Income1.57M
EBITDA2.20M
Earnings Per Share (EPS)0.01
Cash Flow
In the last 12 months, operating cash flow was 83.00K and capital expenditures -225.00K, giving a free cash flow of -142.00K billion.
Operating Cash Flow83.00K
Free Cash Flow-142.00K
Free Cash Flow per Share>-0.01
Dividends & Yields
Omega Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.90
52-Week Price Change-18.57%
50-Day Moving Average3.18
200-Day Moving Average3.21
Relative Strength Index (RSI)32.02
Average Volume (3m)243.49K
Important Dates
Omega Diagnostics upcoming earnings date is Nov 20, 2025, TBA (Confirmed).
Last Earnings DateAug 19, 2025
Next Earnings DateNov 20, 2025
Ex-Dividend Date―
Financial Position
Omega Diagnostics as a current ratio of 3.62, with Debt / Equity ratio of 3.06%
Current Ratio3.62
Quick Ratio3.23
Debt to Market Cap0.03
Net Debt to EBITDA-2.06
Interest Coverage Ratio-37.65
Taxes
In the past 12 months, Omega Diagnostics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Omega Diagnostics EV to EBITDA ratio is 1.25, with an EV/FCF ratio of -19.35.
EV to Sales0.33
EV to EBITDA1.25
EV to Free Cash Flow-19.35
EV to Operating Cash Flow33.11
Balance Sheet
Omega Diagnostics has £4.87M in cash and marketable securities with £349.00K in debt, giving a net cash position of £4.52M billion.
Cash & Marketable Securities£4.87M
Total Debt£349.00K
Net Cash£4.52M
Net Cash Per Share£0.02
Tangible Book Value Per Share£0.03
Margins
Gross margin is 60.08%, with operating margin of -7.68%, and net profit margin of 18.80%.
Gross Margin60.08%
Operating Margin-7.68%
Pretax Margin18.80%
Net Profit Margin18.80%
EBITDA Margin26.39%
EBIT Margin19.00%
Analyst Forecast
The average price target for Omega Diagnostics is £3.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target£3.00
Price Target Upside5.26% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-14.77%
EPS Growth Forecast―